MOGAT2 and neoplasm: Next, we observed MOGAT3, but not MOGAT1 or MOGAT2, markedly elevated in resistant PDX tumors and RKO EC-R cells compared with respective sensitive tumor cells (Figure 3A and Supplemental Figure 3C).